Is semaglutide good for weight loss? Yes — trials show about 15% average weight loss. See who qualifies, dosing, and how it compares to tirzepatide.
Yes — semaglutide is one of the most effective weight-loss medications approved in the United States, and it helps most people with obesity lose a clinically meaningful amount of weight. In large trials, adults taking semaglutide 2.4 mg lost about 15% of their body weight on average, while those on placebo lost about 2%. It is not a cure, and results depend on the dose, how long you stay on it, and the eating and activity habits you build alongside it.
What Semaglutide Is and How It Works
Semaglutide is a GLP-1 receptor agonist, which means it mimics a hormone your gut releases after you eat. It slows how quickly the stomach empties and acts on appetite centers in the brain, so you feel full sooner and stay full longer.
The same molecule is sold under several brand names, which causes a lot of confusion. Wegovy is FDA-approved for chronic weight management, Ozempic is approved for type 2 diabetes, and Rybelsus is an oral form approved for diabetes.
How Much Weight Do People Lose on Semaglutide?
Most people who stay on semaglutide lose a meaningful amount of weight, and a substantial minority lose a great deal. The table below summarizes average results from the major STEP trials.
| Treatment | Trial | Average weight loss | Duration |
|---|---|---|---|
| Semaglutide 2.4 mg | STEP 1 | About 14.9% | 68 weeks |
| Semaglutide 2.4 mg with type 2 diabetes | STEP 2 | About 9.6% | 68 weeks |
| Placebo | STEP 1 | About 2.4% | 68 weeks |
Averages hide a wide range of individual results. In STEP 1, about 86% of participants lost at least 5% of their body weight, and roughly one in three lost 20% or more.
Semaglutide also tends to lower blood pressure, improve cholesterol levels, and reduce blood sugar in people with type 2 diabetes. Those changes matter as much as the number on the scale.
Who Semaglutide Is For
Semaglutide 2.4 mg is approved for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition. Examples include type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, and metabolic liver disease.
People tend to get the best results when they:
- Have already tried diet and exercise without lasting results.
- Have a weight-related health condition that improves with weight loss.
- Can commit to ongoing treatment, follow-up visits, and dose adjustments.
Semaglutide is not intended for people who are already at a healthy weight. It is also not a short-term fix — weight usually returns after the medication is stopped, because appetite hormones go back to their previous levels.
Injection vs. Oral Semaglutide
Weekly injections are the most studied form for weight management, but a daily tablet is now part of the conversation. Many patients searching for semaglutide oral for weight loss are weighing convenience against effectiveness.
| Form | Example | Schedule | Studied weight-loss dose | Notes |
|---|---|---|---|---|
| Injection | Wegovy | Once weekly | 2.4 mg | Most trial data; some pens need refrigeration |
| Tablet | Rybelsus, oral Wegovy | Once daily | 25 mg in trials | No needles; must be taken on an empty stomach |
The tablet has to be swallowed on an empty stomach with a small sip of water, then you wait at least 30 minutes before eating, drinking, or taking other medications. That routine is a real drawback for some people, even though it avoids injections.
Whichever form you use, treatment starts low and moves up gradually. The typical starting dose of semaglutide for weight loss is 0.25 mg once weekly, a dose that is meant to help your body adjust rather than to produce weight loss on its own.
If you have ever wondered why increase dose of semaglutide for weight loss happens every few weeks, the reason is simple: appetite suppression usually grows as the dose rises, and doctors raise it in steps to keep nausea and other side effects manageable.
Side Effects and Safety
Nausea is the most common side effect, followed by diarrhea, vomiting, constipation, and stomach pain. These symptoms are usually worst in the first week or two after a dose increase, then they settle down.
Rare but serious risks include pancreatitis, gallbladder disease, and bowel obstruction. Semaglutide is not recommended during pregnancy, and it is used cautiously in people with a history of pancreatitis or certain thyroid tumors.
Some clinics add vitamin B12 to semaglutide treatment, and semaglutide with b12 for weight loss reviews are easy to find online. There is no strong evidence that B12 itself increases weight loss; it is usually added because GLP-1 medications can reduce food intake and, in some people, lower B12 levels.
Semaglutide is a prescription medication, and anyone considering it should talk with a licensed healthcare professional about their history, risks, and alternatives.
How Semaglutide Compares With Tirzepatide
Tirzepatide (Zepbound) targets both GLP-1 and GIP, and in a head-to-head trial it produced somewhat greater average weight loss than semaglutide 2.4 mg.
| Medication | Hormones targeted | Average weight loss | Form |
|---|---|---|---|
| Semaglutide 2.4 mg | GLP-1 | About 15% | Weekly injection |
| Tirzepatide 15 mg | GLP-1 and GIP | About 21% | Weekly injection |
The answer to tirzepatide vs semaglutide which is better for weight loss is not the same for every patient. Insurance coverage, cost, side-effect tolerance, and supply often decide the choice more than a few percentage points of average weight loss.
The bottom line: semaglutide is a proven, FDA-approved option for chronic weight management, and it works well for many people with obesity. It is not risk-free, it is not a cure, and it works best as part of a long-term plan supervised by a clinician.
Frequently Asked Questions
How much weight can you lose with semaglutide?
Participants in the STEP 1 trial lost an average of about 15% of their body weight over 68 weeks on semaglutide 2.4 mg. Individual results range widely, with some people losing more than 20% and others losing less than 5%. Response tends to improve with higher doses and longer treatment.
What happens if you stop taking semaglutide?
Most people regain much of the weight they lost after stopping, because appetite and hunger signals return to their previous levels. Extension data from the STEP 1 trial found that participants regained roughly two-thirds of their lost weight within a year of stopping treatment. Long-term use is usually required to maintain results.
Is oral semaglutide as effective as the injection for weight loss?
The tablet and injection forms have not been compared head-to-head in a large weight-loss trial. In the OASIS 4 trial, oral semaglutide 25 mg produced about 16.6% average weight loss over 64 weeks, which is in the same range as the injectable 2.4 mg dose. The tablet is harder to use consistently because it must be taken on an empty stomach.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.